A Study of ASP2215 Versus Salvage Chemotherapy In Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FMS-like Tyrosine Kinase 3 (FLT3) Mutation
Astellas Pharma Inc
Astellas Pharma Inc
Astellas Pharma Inc
City of Hope Medical Center
National Cancer Institute (NCI)
Sanofi
Children's Oncology Group
City of Hope Medical Center
City of Hope Medical Center
Thomas Jefferson University
University of Pittsburgh
Arog Pharmaceuticals, Inc.
Arog Pharmaceuticals, Inc.
Cornerstone Pharmaceuticals
University of Florida
Emory University
Roswell Park Cancer Institute
St. Jude Children's Research Hospital
Children's Oncology Group
Medical College of Wisconsin
Therapeutic Advances in Childhood Leukemia Consortium
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)
OHSU Knight Cancer Institute
Fred Hutchinson Cancer Center
Barbara Ann Karmanos Cancer Institute
Fred Hutchinson Cancer Center
Massachusetts General Hospital
Washington University School of Medicine
Washington University School of Medicine
National Cancer Institute (NCI)
City of Hope Medical Center
St. Jude Children's Research Hospital
Sanofi
University of Chicago
Case Comprehensive Cancer Center
St. Jude Children's Research Hospital